Geographic patterns of hepatocellular carcinoma mortality with exposure to iron in groundwater in Taiwanese population: An ecological study

BMC Public Health

Volumn 13, Issue 1, 2013, Pages

  Shyu, Horng Jeng ^a,b   Lung, Chia Chi ^c,d   Ho, Chien Chang ^e   Sun, Yi Hua Iris ^c   Ko, Pei Chieh ^c   Huang, Jing Yang ^c   Pan, Chia Chen ^c   Chiang, Yi Chen ^c,d   Chen, Shih Chang ^f   Liaw, Yung Po ^c,d  

^a JEN AI HOSPITAL   (Taiwan)

^b ASIA UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e YUANPEI UNIVERSITY   (Taiwan)

^f NATIONAL ILAN UNIVERSITY   (Taiwan)

Author keywords

Age standardized mortality; Geographical information systems; Groundwater; Hepatocellular carcinoma; Iron; Land subsidence

Indexed keywords

GROUND WATER; IRON;

ADOLESCENT; ARTICLE; CHEMISTRY; CHILD; CLUSTER ANALYSIS; ENVIRONMENTAL EXPOSURE; FEMALE; GEOGRAPHIC INFORMATION SYSTEM; HUMAN; INFANT; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MEDICAL GEOGRAPHY; MORTALITY; PRESCHOOL CHILD; REGISTER; RISK FACTOR; TAIWAN; VERY ELDERLY;

ADOLESCENT; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; ENVIRONMENTAL EXPOSURE; FEMALE; GEOGRAPHIC INFORMATION SYSTEMS; GEOGRAPHY, MEDICAL; GROUNDWATER; HUMANS; INFANT; IRON; LIVER NEOPLASMS; MALE; REGISTRIES; RISK FACTORS; TAIWAN;

MLCS; MLOWN;

EID: 84876083364     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-13-352     Document Type: Article

References (48)

1. Department of Health (DOH), Vital statistics, 2007 Taiwan: Department of Health, the Executive Yuen 2008
2. Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B. Yuen MF, Tanaka Y, Fong DY, Fung J, Wong DK, Yuen JC, But DY, Chan AO, Wong BC, Mizokami M, Lai CL, J Hepatol 2009 50 80 88 10.1016/j.jhep.2008.07.023 18977053
3. Hepatitis B virus infection. Liaw YF, Chu CM, Lancet 2009 373 582 592 10.1016/S0140-6736(09)60207-5 19217993
4. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, Liang DC, Shau WY, Chen DS, N Engl J Med 1997 336 1855 1859 10.1056/NEJM199706263362602 9197213
5. Seroepidemiology of hepatitis B virus infection in children: Ten years of mass vaccination in Taiwan. Chen HL, Chang MH, Ni YH, Hsu HY, Lee PI, Lee CY, Chen DS, JAMA 1996 276 906 908 10.1001/jama.1996.03540110060032 8782640
6. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. Chang MH, You SL, Chen CJ, Liu CJ, Lee CM, Lin SM, Chu HC, Wu TC, Yang SS, Kuo HS, Chen DS, J Natl Cancer Inst 2009 101 1348 1355 10.1093/jnci/djp288 19759364
7. Epidemiological characteristics and risk factors of hepatocellular carcinoma. Chen CJ, Yu MW, Liaw YF, J Gastroenterol Hepatol 1997 12 294 308 10.1111/j.1440-1746.1997.tb00513.x
8. Low prevalences of HBV and HCV infection in patients with primary biliary cirrhosis in Taiwan: a case control study. Chien RN, Sheen IS, Liaw YF, J Gastroenterol Hepatol 1993 8 574 576 10.1111/j.1440-1746.1993.tb01655.x 7506585
9. Mortality of iron-steel workers in Anshan, China: a retrospective cohort study. Hoshuyama T, Pan G, Tanaka C, Feng Y, Yu L, Liu T, Liu L, Hanaoka T, Takahashi K, Int J Occup Environ Health 2006 12 193 202 16967824
10. Iron overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal. Huang X, Mutat Res 2003 533 153 171 10.1016/j.mrfmmm.2003.08.023 14643418
11. Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis. Sorrentino P, D'Angelo S, Ferbo U, Micheli P, Bracigliano A, Vecchione R, J Hepatol 2009 50 351 357 10.1016/j.jhep.2008.09.011 19070395
12. Aflatoxin B1 exposure, hepatitis B virus infection, and hepatocellular carcinoma in Taiwan. Wu HC, Wang Q, Yang HI, Ahsan H, Tsai WY, Wang LY, Chen SY, Chen CJ, Santella RM, Cancer Epidemiol Biomarkers Prev 2009 18 846 853 10.1158/1055-9965.EPI-08-0697 19273485
13. Vegetable consumption, serum retinol level, and risk of hepatocellular carcinoma. Yu MW, Hsieh HH, Pan WH, Yang CS, CHen CJ, Cancer Res 1995 55 1301 1305 7882326
14. Toward the identification of communities with increased tobacco-associated cancer burden: application of spatial modeling techniques. Dietz NA, Sherman R, Mackinnon J, Fleming L, Arheart KL, Wohler B, Lee DJ, J Carcinog 2011 10 22 10.4103/1477-3163.85184 22013392
15. The spatial distribution of esophageal and gastric cancer in Caspian region of Iran: an ecological analysis of diet and socio-economic influences. Mohebbi M, Wolfe R, Jolley D, Forbes AB, Mahmoodi M, Burton RC, Int J Health Geogr 2011 10 13 10.1186/1476-072X-10-13 21324144
16. Arsenic and cancers. Chen CJ, Kuo TL, Wu MM, Lancet 1988 1 414 415 2893213
17. Statistical methods in cancer research. Volume IV. Esteve J, Benhamou E, Raymond L, Descriptive epidemiology Lyon: (IARC Scientific Publications No. 128), International Agency for Research on cancer 1994 52
18. Survival rate for liver cancer in Taiwan. Lee CL, Ko YC, Choong CS, Zhonghua Yi Xue Za Zhi 2000 63 16 20 10645046
19. Seroprevalences of hepatitis B and C viruses and Helicobacter pylori infection in a small, isolated population at high risk of gastric and liver cancer. Chen SY, Liu TY, Chen MJ, Lin JT, Sheu JC, Chen CJ, Int J Cancer 1997 71 776 779 10.1002/(SICI)1097-0215(19970529)71:5<776::AID-IJC14>3.0.CO;2-6 9180145
20. A nested case-control study on association between hepatitis C virus antibodies and primary liver cancer in a cohort of 9,775 men in Taiwan. Chang CC, Yu MW, Lu CF, Yang CS, Chen CJ, J Med Virol 1994 43 276 280 10.1002/jmv.1890430315 7523582
21. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. Chen DS, Kuo GC, Sung JL, Lai MY, Sheu JC, Chen PJ, Yang PM, Hsu HM, Chang MH, Chen CJ, J Infect Dis 1990 162 817 822 10.1093/infdis/162.4.817 2169497
22. A case-control study of primary hepatocellular carcinoma in Taiwan. Lu SN, Lin TM, Chen CJ, Chen JS, Liaw YF, Chang WY, Hsu ST, Cancer 1988 62 2051 2055 10.1002/1097-0142(19881101)62:9<2051::AID-CNCR2820620930>3.0.CO;2-1 2844388
23. Mutual confounding and interactive effects between hepatitis C and hepatitis B viral infections in hepatocellular carcinogenesis: a population-based case-control study in Taiwan. Sun CA, Farzadegan H, You SL, Lu SN, Wu MH, Wolfe L, Hardy W, Huang GT, Yang PM, Lee H, Chen CJ, Cancer Epidemiol Biomarkers Prev 1996 5 173 178 8833617
24. Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan. Yu MW, You SL, Chang AS, Lu SN, Liaw YF, Chen CJ, Cancer Res 1991 51 5621 5625 1655259
25. Community-based hepatocellular carcinoma screening in seven townships in Taiwan. Chen CJ, Lu SN, You SL, Wu MH, Wang LY, Lee LT, Huang GT, Yang PM, Lee HS, J Formos Med Assoc 1995 94 94 102
26. Prevalence of hepatitis B surface antigen carrier status among residents in the endemic area of chronic arsenicism in Taiwan. Lu JN, Chen CJ, Anticancer Res 1991 11 229 233 2018356
27. Secular trend and geographical variation in hepatitis A infection and hepatitis B carrier rate among adolescents in Taiwan: an island-wide survey. Wang LY, Cheng YW, Chou SJ, Hsieh LL, Chen CJ, J Med Virol 1993 39 1 5 10.1002/jmv.1890390102 8423454
28. Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants. Chen CH, Yang PM, Huang GT, Lee HS, Sung JL, Sheu JC, J Formos Med Assoc 2007 106 148 155 10.1016/S0929-6646(09)60231-X 17339159
29. Increased liver iron stores in patients with hepatocellular carcinoma developed on a noncirrhotic liver. Turlin B, Juguet F, Moirand R, Le Quilleuc D, Loréal O, Campion JP, Launois B, Ramée MP, Brissot P, Deugnier Y, Hepatology 1995 22 446 450 7635411
30. Iron, hemochromatosis, and hepatocellular carcinoma. Kowdley KV, Gastroenterology 2004 127 79 S86 10.1016/j.gastro.2004.09.019 15508107
31. Hepatitis C and hepatocellular carcinoma. Di Bisceglie AM, Hepatology 1997 26 34 S38 10.1002/hep.510260706
32. Normalization of elevated hepatic 8-hydroxy-20-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet. Kato J, Kobune M, Nakamura T, Kuroiwa G, Takada K, Takimoto R, Sato Y, Fujikawa K, Takahashi M, Takayama T, Ikeda T, Niitsu Y, Cancer Res 2001 61 8697 8702 11751387
33. A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: a multicenter, prospective, randomized, controlled trial in Japan. Yano M, Hayashi H, Yoshioka K, Kohgo Y, Saito H, Niitsu Y, Kato J, Iino S, Yotsuyanagi H, Kobayashi Y, Kawamura K, Kakumu S, Kaito M, Ikoma J, Wakusawa S, Okanoue T, Sumida Y, Kimura F, Kajiwara E, Sata M, Ogata K, J Gastroenterol 2004 39 570 574 15235875
34. Possible correlation between iron deposition and enhanced proliferating activity in hepatitis C virus-positive hepatocellular carcinoma in Myanmar (Burma). Soe K, Hishikawa Y, Fukuzawa Y, Win N, Yin KS, Win KM, Myint AA, Koji T, J Gastroenterol 2007 42 225 235 10.1007/s00535-006-1993-9 17380281
35. Accelerated proliferation of hepatocytes in rats with iron overload after partial hepatectomy. An S, Soe K, Akamatsu M, Hishikawa Y, Koji T, Histochem Cell Biol 2012 138 773 786 10.1007/s00418-012-0994-4 22825839
36. The effect of clay dehydration on land subsidence in the Yun-Lin coastal area, Taiwan. Liu CW, Lin WS, Shang C, Liu SH, Environ Geol 2001 40 518 527 10.1007/s002540000193
37. World Health Organization (WHO), Iron in Drinking-water. Background document for development of WHO Guidelines for Drinking-water Quality Geneva: World Health Organization 1996
38. Iron metabolism and toxicity. Papanikolaou G, Pantopoulos K, Toxicol Appl Pharmacol 2005 202 199 211 10.1016/j.taap.2004.06.021 15629195
39. Role of iron in carcinogenesis: cancer as a ferrotoxic disease. Toyokuni S, Cancer Sci 2009 100 9 16 10.1111/j.1349-7006.2008.01001.x 19018762
40. Hepatic iron overload and hepatocellular carcinoma. Kew MC, Cancer Lett 2009 286 38 43 10.1016/j.canlet.2008.11.001 19081672
41. Body iron store as a predictor of oxidative DNA damage in healthy men and women. Hori A, Mizoue T, Kasai H, Kawai K, Matsushita Y, Nanri A, Sato M, Ohta M, Cancer Sci 2010 101 517 522 10.1111/j.1349-7006.2009.01394.x 19895603
42. Iron-binding proteins and risk of cancer in Taiwan. Stevens RG, Beasley RP, Blumberg BS, J Natl Cancer Inst 1986 76 605 610 3007843
43. Perspectives in iron metabolism. Finch CA, Huebers H, N Engl J Med 1982 306 1520 1528 10.1056/NEJM198206243062504 7043270
44. Serum ferritin level remains a reliable marker of bone marrow iron stores evaluated by histomorphometry in hemodialysis patients. Rocha LA, Barreto DV, Barreto FC, Dias CB, Moysés R, Silva MR, Moura LA, Draibe SA, Jorgetti V, Carvalho AB, Canziani ME, Clin J Am Soc Nephrol 2009 4 105 109 10.2215/CJN.01630408 18842949
45. What is the evidence for gender differences in ferritin and haemoglobin? Rushton DH, Barth JH, Crit Rev Oncol Hematol 2010 73 1 9 10.1016/j.critrevonc. 2009.03.010 19394859
46. The effect of blood donation frequency on iron status. Røsvik AS, Ulvik RJ, Wentzel-Larsen T, Hervig T, Transfus Apher Sci 2009 41 165 169 10.1016/j.transci.2009.09.017 19819187
47. Relative importance of female-specific and non-female-specific effects on variation in iron stores between women. Whitfield JB, Treloar S, Zhu G, Powell LW, Martin NG, Br J Haematol 2003 120 860 866 10.1046/j.1365-2141.2003.04224.x 12614223
48. Factors affecting the concentrations of ferritin in serum in a healthy Australian population. Leggett BA, Brown NN, Bryant SJ, Duplock L, Powell LW, Halliday JW, Clin Chem 1990 36 1350 1355 2372951